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Background/aim: Diagnosis of interstitial lung diseases requires a multidisciplinary approach, and a gold standard for histological
diagnosis is open lung biopsy. Transbronchial lung biopsy (TBLB) and in recent years an alternative method, cryobiopsy (TBLC), are
used for the diagnosis of parenchymal lung lesions. The aim of this study is to compare the efficacy of concomitant conventional TBLB
and TBLC.
Materials and methods: A total of 82 patients who underwent TBLC for diagnosis of diffuse parenchymal lung diseases at Dr. Suat
Seren Chest Diseases and Surgery Training and Research Hospital between 2015 and 2018 were screened retrospectively and included in
the study. Of the patients, 53.7% (n: 44) were male, and 46.4% (n:38) of them were female. The mean age was 58.37 (±9.33) years. First
TBLB and then TBLC were performed to all patients in the same session and their diagnostic performances were compared.
Results: Although both procedures were done in the same session, 45 patients (54.9%) were diagnosed with TBLB and 75 patients
(91.5%) were diagnosed with TBLC (P ˂ 0.001). Hemorrhage was observed in 39 patients (47.6%), but only one had a massive
hemorrhage. Pneumothorax was observed in 6 patients (7.3%) and none of them required tube drainage.

Conclusion: Transbronchial lung cryobiopsy is a promising technique for the diagnosis of parenchymal lung diseases compared to
transbronchial lung biopsy.
Key words: Transbronchial lung biopsy, transbronchial lung cryobiopsy, parenchymal lung disease

1. Introduction
Diagnosis of interstitial lung diseases (ILD) requires a
multidisciplinary approach and the gold standard for
histological diagnosis is surgical lung biopsy (SLB).
Bronchoscopy is the most commonly used diagnostic tool
in lung lesions. The diagnostic success of conventional
transbronchial lung biopsy (TBLB) has varied between
various parenchymal lung diseases, and its use as an
alternative diagnostic tool has increased in recent years
due to the use of cryoprobes with adequate sampling and
low rate of side effects.
ILD is a heterogeneous group consisting of more than
200 different disorders, requiring a multidisciplinary
approach for diagnosis. Invasive procedures such as
bronchoscopic procedures and open lung biopsy are often
required for the diagnosis [1,2]. Idiopathic pulmonary
fibrosis (IPF), also known as usual interstitial pneumonia
(UIP), is a chronic, progressive, and fibrotic ILD. Although
the etiology of IPF is unknown, it has a characteristical
image and histological pattern. IPF has a very poor
prognosis and the median survival rate is 3 years [3].

Since they are frequently confused with diseases such as
congestive heart failure (CHF) and chronic obstructive
pulmonary disease (COPD), patients lose their time by
following these diagnoses. Because of the short survival
time early diagnosis has a vital role [4]. While half of
the patients with IPF are diagnosed radiologically, tissue
biopsy is required for the diagnosis of the other half.
Correct diagnosis must be made for a better treatment and
prognosis [5].
In the mid-1960s, TBLB was used for the diagnosis
of diffuse parenchymal lung diseases [6,7[. Although
conventional TBLB provides the diagnosis of sarcoidosis,
neoplasia, some infections and cryptogenic organized
pneumonia (COP), in most cases the diagnosis cannot be
reached due to the small samples and the crush artifact of
the biopsy material [8–10]. In patients with ILD, although
the samples taken with conventional TBLB are evaluated
together with clinical and radiological findings, only 20–
30% of patients are truly diagnosed [11].
Cryoprobes were first used in bronchoscopy in 1977
[12]. Transbronchial lung biopsy with cryoprobe (TBLC)
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is a relatively recent technique for lung parenchyma
sampling [13]. After the tissue specimen is taken, the
bronchoscope and cryoprobe were removed together, and
this provides an advantage in avoiding crush artifacts [14].
TBLC specimens are better in quality because they are
larger in size and contain no artifact compared with TBLB,
so the diagnosis rate is higher [13–15]. The disadvantage
of this technique is that it is closer to surgical technique
and it should be performed under general anesthesia and
needs tracheal intubation [5,16,17].
We planned this study to see how the TBLC increases
the chance to diagnose the diffuse parenchymal lung
diseases comparing to TBLB.
2. Materials and methods
A total of 82 patients who underwent TBLC for diagnosis of
diffuse parenchymal lung diseases at Dr. Suat Seren Chest
Diseases and Surgery Training and Research Hospital
between 2015 and 2018 were screened retrospectively and
included in the study. Of the patients, 53.7% (n:44) were
male, and 46.4% (n:38) of them were female. The mean age
was 58.37 (±9.33) years. All these patients were suspected
of having ILD, but could not be diagnosed with history,
physical examination, laboratory tests, and high resolution
computed tomography (HRCT) of the thorax. All patients
were older than 18 years. None of them had coagulopathy,
pulmonary hypertension, or severe cardiac disease. All
patients were informed about the procedure and written
informed consent was obtained from all patients. All
bronchoscopies were performed by pulmonologists.
The study was approved by the local ethics committee
(07/11/2018 – 8566).
The procedure was performed in the operating room.
Oxygen saturation, blood pressure, electrocardiogram,
and transcutaneous partial carbon dioxide pressure were
monitored during the procedure. Accompanied by an
anesthesiologist, all patients were intubated with a rigid
bronchoscope (Dutau-Novatech, Bronchial Tube size 12,
black, 10.7 mm working canal, 35 cm length) by providing
deep sedation with midazolam, fentanyl citrate, and
propofol. The flexible bronchoscope (Olympus CV 170,
with a diameter of 2.8 mm) was passed through the rigid
bronchoscope. Before the procedure, TBLB was performed
with fluoroscopy guidance from the target area which was
identified by the radiologist. The balloon (Broncho Dilator
Balloon Catheter) was then placed in the target segment
through the rigid bronchoscope. Cryoprobe (Erbolryo CA,
ERBE, 2.4 mm in diameter, 900 mm length) was sent to
the same segment through a flexible bronchoscope. It was
advanced to a distance of 10–20 mm to the chest wall with
the guidance of fluoroscopy. Cooling with N2O was carried
out for 3 to 6 s. After freezing, a flexible bronchoscope
was removed with the cryoprobe. The sample was kept
in saline solution and a formalin solution was used for
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fixation. The balloon was inflated immediately after TBLC
was removed. The procedure was repeated 2 to 5 times.
Bleeding is defined as “mild” if it is less than 10 mL and is
controlled by endoscopic aspiration; “moderate’’ if it is 10–
40 mL and requires bronchial occlusion and/or cold saline
infusion; and “severe” if it is more than 40 mL and requires
transfusion, surgical interventions and needs intensive
care unit admission. After bleeding control, sedation was
stopped and patients were extubated. After the procedure,
the patients were kept under close observation in the
intensive care unit for 2 h. After 4 h, pneumothorax control
was performed by chest radiography.
Clinical information, radiological findings, and
histopathological results were then reviewed by clinicians,
radiologist, and pathologists, and a multidisciplinary
diagnosis was made.
2.1. Statistical analysis
The age of patients was presented as mean standard
deviation, while all other qualitative variables were
presented as frequency and percentage. The comparison
between the two biopsy procedures was analyzed with
McNemar’s test. The relationship between the diagnostic
yield with the size and number of biopsies was investigated
with Linear-by-Linear Associaton test. All statistical
analysis was performed with SPSS (SPSS Inc., version
25.0), and the level of significance was predetermined as
0.05.
3. Results
Of the patients, 62.2% had diffused radiological
involvement and 37.8% had localized involvement. In
the same session before the TBLC procedure, all patients
underwent TBLB with scopy from the most affected area.
Most of the biopsies (63.4%) were taken from the right
lower lobe (Table 1). The mean number of biopsies was
3, while the mean biopsy size was 2–3 mm. There was no
relationship between the number of biopsies and diagnosis
rate, and the size of specimen and diagnosis rate.
Overall, a specific pathological diagnosis was revealed
in 75/82 (91.5%) in TBLC cases while 45/82 (54.9%)
in TBLB cases (P ˂ 0.001). UIP was the most common
disease (21 patients) in the TBLC group. Only one patient
was diagnosed with UIP in the TBLB group, although the
procedure was performed under scopy. Hypersensitivity
pneumonitis (HSP) was detected in 11 cases by using
TBLC, and in 2 cases by using TBLB. Ten organizing
pneumonia (OP) were detected by using TBLC and 7 by
using TBLB. Nonspecific interstitial pneumonia (NSIP)
was detected by TBLC in 6 cases, and by TBLB in 2 cases;
primary lung cancer was detected by TBLC in 3 cases and
by TBLB in 1 case; lung metastasis was detected by TBLC
in 2 cases and by TBLB in 2 cases. All the pathological
diagnoses detected are shown in Table 2.
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Table 1. The lung biopsy regions.

Table 2. Diagnosis rates with TBLB and TBLC.

Biopsy regions

%

Diagnosis

TBLB n(%)

TBLC n (%)

Right lower lobe

63.4

IPF

1 (1.2)

21 (25.6)

Left lower lobe

24.4

Nonspecific changes

16 (19.5)

13 (15.9)

Right upper lobe

8.5

HSP

2 (2.4)

11 (13.4)

Right upper and lower lobe

1.2

OP

7 (8.5)

10 (12.2)

Left upper lobe

1.1

Nondiagnostic

37 (45.1)

7 (8.5)

Left upper and lower lobe

1.1

NSIP

2 (2.4)

6 (7.3)

Lung cancer

1 (1.2)

3 (3.7)

Unclassified ILD

0 (0)

2 (2.4)

Sarcoidosis

1 (1.2)

2 (2.4)

Metastases

2 (2.4)

2 (2.4)

Normal lung tissue

1 (1.2)

2 (2.4)

Follicular bronchiolit

1 (1.2)

1 (1.2)

Churge Strauss

0 (0)

1 (1.2)

Pneumoconiosis

1 (1.2)

1 (1.2)

Safety outcomes are summarized in Table 3.
Complications were observed in 45 of the 82 patients
included in the study. In 39 (47.6%) patients, bleeding was
observed during the procedure, 23 of them had mild and
15 of them had moderate bleeding. One patient had severe
bleeding requiring temporary intubation and controlled
with supportive therapy. Pneumothorax occurred in 6
(7.3%) patients that did not require chest-tube drainage.
4. Discussion
In this study, TBLB and TBLC were performed for all
patients in the same session for diagnostic purposes, and
their diagnostic performance was compared. As a result,
the rate of diagnosis was found to be much higher in
patients who underwent TBLC.
Diagnosis of ILD requires a multidisciplinary approach
of pulmonology, radiology, and pathology departments.
Histopathological diagnosis is necessary if the clinical
and laboratory findings suggest ILD, but the differential
diagnosis cannot be made by radiological features. SLB is
the gold standard for the diagnosis of ILD [1]. However,
TBLB is often preferred rather than SLB in daily practice
because of its high complications and high cost [18]. On
the other hand, the alveolar parenchymal tissue is not
adequately monitored or can be nondiagnostic because
of the biopsy sample taken with TBLB is too small and
contains crush artifacts, which reduces the diagnostic
efficiency [19]. In recent years, the larger biopsy specimens
are taken with TBLC and do not contain crush artifacts,
and since it is performed in the presence of scopyguided biopsy from the area of the lesions the diagnosis
rate is increased [13,15]. The disadvantages are that it is
technically similar to the surgical procedure because it
is performed in the operating room and under general
anesthesia, and complications such as pneumothorax and
bleeding are slightly higher than TBLB [1,5,16].
In this study, we demonstrated better diagnostic
performance with TBLC, and this created an advantage in
interstitial lung diseases that were difficult to diagnose. The
complications were observed in 45 (54.9%) of 82 patients.

Table 3. Complications of the patients.
Complications

n (%)

1. Bleeding

39 (47.6)

a. Mild

23 (28.04)

b. Moderate

15 (18.29)

c. Severe

1 (1.21)

2. Pneumothorax

6 (7.3)

The most common complication was bleeding during the
procedure in 39 (47.6%) patients. Of these, 23 (28%) had
mild, 15 (18.3%) had moderate, and 1 (1.2%) had severe
bleeding. No treatment was required for mild bleeding,
whereas moderate bleeding was controlled with cold
saline solution, bronchial blockers, and Fogarty balloon.
The patient with severe bleeding required intubation and
transfusion and was monitored in the intensive care unit
for 2 days. No cases of fatal bleeding were observed.
In our study, the bleeding complication rates in the
TBLC-treated group were significantly lower than those
reported by Hetzel et al. (61.8% mild bleeding, 18.2%
severe bleeding) and another study by Pajares et al. (30.8%
mild, 56.4% moderate bleeding) [15,19]. We observed
that our bleeding complication rates decreased as our
procedure experience increased.
Another complication of the TBLC procedure is
pneumothorax, and its rate is variable in the literature
ranging from 1% to 30%. Pneumothorax without tube
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drainage was detected in 6 (7.3%) of our patients. These
rates of pneumothorax were very close to those reported
in the literature. Among these studies, this rate was found
to be 7.7% in Pajares et al. [15] and 4.95% in Gershmann
et al. [20].
The diagnostic efficiency of TBLC is considerably
higher than that of TBLB because the TBLC procedure
allows larger tissue samples to be taken [13,15].
In our patient group, the maximum number of biopsies
performed in the same procedure as TBLC was 5 (mean 3)
and the largest of the samples was 8mm (mean 2–3 mm).
The samples taken with TBLB were found to be so small
that the pathology physicians could not determine the size.
As expected, the tissue samples obtained in the TBLC arm
were much larger and the diagnosis rate of the procedure
was much higher. Thirty-seven (45.1%) nondiagnostic
materials were observed in TBLB arm compared to 7
(8.5%) nondiagnostic materials in TBLC arm.
Of the 82 patients, 21 were diagnosed with Usual
Interstitial Pneumonia (UIP) with TBLC, while this
number was only 1 with TBLB. We have seen that almost
all of these patients who are rapidly progressing and whose
treatment should be started as soon as possible can be
missed with TBLB. The second most common diagnosis
was HSP and 11 of them diagnosed with TBLC, and two

of them with TBLB. Although there are not many studies
comparing TBLB and TBLC in the literature, BangoAlvarez A et al. reported 22 UIP, 10 OP, 11 NSIP, and 12
silicosis diagnoses in their study involving 106 patients
[21]. In the study by Ramaswamy et al. four out of ten ILD
patients were diagnosed with TBLB, and seven with TBLC
[22]. Casoni et al. diagnosed 47 of 69 patients with UIP,
9 with NSIP, 2 with desquamative interstitial pneumonia,
1 with OP, 1 with eosinophilic pneumonia, 1 with diffuse
alveolar damage, 1 with HSP, and 1 with follicular
bronchiolitis with TBLC.
Although we explained the superiority of TBLC to
the TBLB because of the larger biopsy size, we could not
detect a statistically significant difference between the size
of the tissue and the number of biopsies taken by TBLC
in our study. We attribute this to the fact that the groups
that make up the number and size of the biopsy were not
numerically close to each other and that TBLC was still
more effective than TBLB, and that the crush artifact was
not observed in TBLC.
In conclusion, our study demonstrated higher
diagnostic yield with TBLC compared to TBLB. The
limitation of our study is that it was retrospective. In the
same session, first TBLB and then TBLC were performed,
so the complications could not be compared.
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